| 1 |
35158767 | Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters. | 2022 Jan 19 |
1 |
| 2 |
33603656 | The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study. | 2021 |
2 |
| 3 |
33797705 | Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis. | 2021 Apr |
3 |
| 4 |
33010954 | Targeting the Sphingosine-1-Phosphate Axis for Developing Non-narcotic Pain Therapeutics. | 2020 Nov |
6 |
| 5 |
30785748 | Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P1) Modulator Advanced into Clinical Trials. | 2019 Mar 14 |
1 |
| 6 |
30828332 | Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells. | 2019 |
3 |
| 7 |
31526917 | Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients. | 2019 Dec 15 |
2 |
| 8 |
30083262 | Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine. | 2018 |
1 |
| 9 |
28356890 | Evaluation and Optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 Modulators for the Management of Multiple Sclerosis. | 2017 Mar |
2 |
| 10 |
28716816 | Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance. | 2017 Nov |
1 |
| 11 |
27055778 | Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis. | 2016 Jun |
1 |
| 12 |
27663260 | To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling. | 2016 Nov |
2 |
| 13 |
25582213 | Therapeutic interference with leukocyte recirculation in multiple sclerosis. | 2015 Mar |
2 |
| 14 |
26130058 | Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. | 2015 Nov |
2 |
| 15 |
26648781 | Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study. | 2015 |
1 |
| 16 |
24239768 | Second generation S1P pathway modulators: research strategies and clinical developments. | 2014 May |
1 |
| 17 |
25239520 | Prominence of central sphingosine-1-phosphate receptor-1 in attenuating aβ-induced injury by fingolimod. | 2014 Dec |
3 |
| 18 |
25518386 | [Fingolimod treatment in multiple sclerosis]. | 2014 Nov |
1 |
| 19 |
23518370 | Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. | 2013 May 15 |
1 |
| 20 |
24069553 | Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer. | 2013 Jul 1 |
1 |
| 21 |
22493799 | [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists]. | 2012 Jan |
2 |
| 22 |
22999882 | A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis. | 2012 Sep 21 |
2 |
| 23 |
21464424 | Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. | 2011 Apr 5 |
1 |
| 24 |
21710707 | [Current treatment of multiple sclerosis]. | 2011 Feb |
1 |
| 25 |
24900328 | Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart Rate. | 2011 Jun 9 |
1 |
| 26 |
20413685 | Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. | 2010 Jun |
1 |
| 27 |
19814729 | FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. | 2009 Nov |
1 |
| 28 |
18474015 | Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. | 2008 Jan |
4 |
| 29 |
16365393 | Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection. | 2006 Jan 1 |
1 |
| 30 |
16393960 | Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. | 2006 Jan 15 |
1 |
| 31 |
16549044 | Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. | 2006 Feb |
1 |